Document is current
Any future updates will be listed below
-
Authors
Hey, Jana Christina
Rasamoelina, Tahinamandranto
Razafindrakoto, Anjarasoa Ravo
Razafindralava, Nantenaina Matthieu
Rasolojaona, Zaraniaina Tahiry
Leyk, Stephanie
Rajasekharan, Sreejith
Wilken, Lucas
Randrianarisoa, Tiana
Rafaralahivoavy, Tojo Rémi
Hainasoa, Jacques
Rakotozandrindrainy, Raphael
Randriamampionona, Njary
Schwarz, Norbert Georg
Jaeger, Anna
Remkes, Aaron
Kutz, Jean-Marc
Rausche, Pia
Kislaya, Irina
Marchese, Valentina
Ehmen, Christa
Deschermeier, Christina
May, Jürgen
Bosurgi, Lidia
Rakotoarivelo, Rivo Andry
Scaturro, Pietro
Fusco, Daniela https://orcid.org/0000-0001-8833-239X
-
Funding
Funding for this research was provided by:
Deutsches Zentrum für Infektionsforschung (TI 03.907, 8008803819)
Bundesministerium für Bildung und Forschung (O1KA21O9A)
Deutsche Forschungsgemeinschaft (499961789)
Bernhard-Nocht-Institut für Tropenmedizin
- License Information
-
More Information
Article History
Received: 13 May 2025
Accepted: 11 September 2025
First Online: 26 September 2025
Declarations
:
: Ethical clearance was obtained from the National Ethics Committee of Madagascar (N°23 MSANP/CERBM, 05/03/2018; N°137 MSANP/SG/AMM/CERBM, 13/06/2023; N°136 MSANP/SG/AMM/CERBM, 13/06/2023) and the Ethics Committee of the Hamburg State Medical Chamber in Germany (PV7019-4419-BO-ff, 30/05/2023; 2022-100793-BO-ff, 17/07/2023; 2021-100743-BO-ff, 08/06/2023). All participants were informed about the aims of the study and its procedures in the local language (Malagasy). Study participation was voluntary, and no monetary incentives were offered. Written informed consent for participation was obtained from all participants. The participants had the right to withdraw from the study at any time without reason. Those positive for schistosome infection at recruitment were offered a treatment of 40 mg/kg praziquantel.
: All co-authors agreed with the text and gave consent for publication.
: CD is the founder and shareholder of Panadea Diagnostics GmbH. All the other authors report that there are no competing interests to declare.
